GCA
EBS icon

Greenwood Capital Associates’s Emergent Biosolutions EBS Stock Holding History

Greenwood Capital Associates’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-16,067
Closed -$660K – 208
2022
Q1 		$660K Buy
16,067
+554
+4% +$24.4K 0.17% 106
2021
Q4 		$674K Buy
15,513
+103
+0.7% +$4.66K 0.1% 167
2021
Q3 		$772K Sell
15,410
-392
-2% -$23.7K 0.12% 137
2021
Q2 		$995K Buy
15,802
+70
+0.4% +$4.5K 0.15% 114
2021
Q1 		$1.46M Buy
15,732
+1,092
+7% +$112K 0.23% 83
2020
Q4 		$1.31M Buy
14,640
+2,939
+25% +$270K 0.22% 84
2020
Q3 		$1.21M Buy
11,701
+43
+0.4% +$4.63K 0.23% 78
2020
Q2 		$922K Buy
11,658
+2,103
+22% +$157K 0.21% 75
2020
Q1 		$553K Sell
9,555
-603
-6% -$34.8K 0.16% 74
2019
Q4 		$548K Buy
10,158
+1,750
+21% +$94.9K 0.12% 102
2019
Q3 		$440K Buy
8,408
+671
+9% +$31.3K 0.11% 99
2019
Q2 		$374K Buy
7,737
+291
+4% +$13.9K 0.09% 118
2019
Q1 		$376K Buy
7,446
+1,125
+18% +$66.4K 0.1% 109
2018
Q4 		$375K Buy
6,321
+742
+13% +$47.8K 0.1% 115
2018
Q3 		$367K Buy
5,579
+26
+0.5% +$1.52K 0.08% 132
2018
Q2 		$280K Buy
5,553
+940
+20% +$49K 0.06% 147
2018
Q1 		$243K Sell
4,613
-246
-5% -$12.3K 0.06% 165
2017
Q4 		$226K Buy
+4,859
New +$205K 0.05% 184

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Greenwood Capital Associates's EBS Position: Q2 2022 in Review

Greenwood Capital Associates sold out of Emergent Biosolutions (EBS) in Q2 2022, closing a stake of 16,067 shares — an estimated $660K sold.

Greenwood Capital Associates first reported a position in EBS in Q4 2017 and held it in 18 quarters. The position peaked at $1.46M in Q1 2021. 232 funds tracked by Wall St. Rank hold EBS as of Q2 2022.

  • Greenwood Capital Associates reported no remaining Emergent Biosolutions position as of Q2 2022 after selling out during the quarter.
  • Greenwood Capital Associates sold 16,067 Emergent Biosolutions shares in Q2 2022, an estimated $660K.
  • Greenwood Capital Associates first reported a position in Emergent Biosolutions in Q4 2017 and held it in 18 quarters.
  • Greenwood Capital Associates's Emergent Biosolutions position peaked at $1.46M in Q1 2021.
  • 232 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2022.

Based on Greenwood Capital Associates's 13F filing for Q2 2022, filed 10 Aug 2022.